As of 2025-07-11, the Relative Valuation of bluebird bio Inc (BLUE) is (446.84) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.97 USD, the upside of bluebird bio Inc based on Relative Valuation is -9090.8%.
The range of the Relative Valuation is (363.20) - (499.24) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.2x - 24.4x | 20.3x |
| Forward P/E multiples | 17.8x - 29.1x | 23.4x |
| Fair Price | (363.20) - (499.24) | (446.84) |
| Upside | -7407.7% - -10145.1% | -9090.8% |
| Date | P/E |
| 2025-05-30 | -0.24 |
| 2025-05-29 | -0.24 |
| 2025-05-28 | -0.24 |
| 2025-05-27 | -0.24 |
| 2025-05-23 | -0.24 |
| 2025-05-22 | -0.24 |
| 2025-05-21 | -0.24 |
| 2025-05-20 | -0.24 |
| 2025-05-19 | -0.24 |
| 2025-05-16 | -0.24 |
| 2025-05-15 | -0.24 |
| 2025-05-14 | -0.24 |
| 2025-05-13 | -0.16 |
| 2025-05-12 | -0.16 |
| 2025-05-09 | -0.17 |
| 2025-05-08 | -0.18 |
| 2025-05-07 | -0.18 |
| 2025-05-06 | -0.19 |
| 2025-05-05 | -0.19 |
| 2025-05-02 | -0.19 |
| 2025-05-01 | -0.20 |
| 2025-04-30 | -0.20 |
| 2025-04-29 | -0.20 |
| 2025-04-28 | -0.21 |
| 2025-04-25 | -0.20 |
| 2025-04-24 | -0.20 |
| 2025-04-23 | -0.20 |
| 2025-04-22 | -0.21 |
| 2025-04-21 | -0.19 |
| 2025-04-17 | -0.20 |
| 2025-04-16 | -0.20 |
| 2025-04-15 | -0.22 |
| 2025-04-14 | -0.23 |
| 2025-04-11 | -0.25 |